Axogen (AXGN) Revenue (2010 - 2026)
Axogen's (AXGN) quarterly Revenue came in at $61.5 million in Q1 2026, up 26.56% year-on-year from $48.6 million in Q1 2025, and up 2.59% quarter-over-quarter from $59.9 million in Q4 2025.
Axogen (AXGN) Revenue (2010 - 2026) Analysis & Trends
Axogen's Revenue history runs 17 years deep, the most recent figure standing at $61.5 million for Q1 2026.
- On a quarterly basis, Revenue rose 26.56% year-over-year to $61.5 million in Q1 2026; TTM through Mar 2026 was $238.1 million, a 22.41% increase from a year earlier, with the FY2025 full-year figure at $225.2 million, up 20.21% from the prior year.
- Revenue advanced to $61.5 million in Q1 2026 per AXGN's latest filing, from $59.9 million in the prior quarter.
- Across five years, Revenue topped out at $61.5 million in Q1 2026 and bottomed at $31.0 million in Q1 2022.
- The 5-year median for Revenue is $42.9 million (2023), against an average of $45.4 million.
- Across the five-year window, Revenue fell 0.1% in 2022 and gained 26.56% in 2026, its largest moves.
- Year by year, Revenue stood at $36.2 million in 2022, then grew by 18.69% to $42.9 million in 2023, then rose by 15.1% to $49.4 million in 2024, then increased by 21.25% to $59.9 million in 2025, then advanced by 2.59% to $61.5 million in 2026.
- Per Business Quant, the three latest AXGN Revenue figures stand at $61.5 million (Q1 2026), $59.9 million (Q4 2025), and $60.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 11.16 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.02 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 9.81 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 5.20 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.65 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.19 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 4.57 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 5.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Axogen | 2.05 Bn | 1.95 Bn | 46.19 Mn | 61.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.46 Mn |
| Dec 31, 2025 | 59.90 Mn |
| Sep 30, 2025 | 60.08 Mn |
| Jun 30, 2025 | 56.66 Mn |
| Mar 31, 2025 | 48.56 Mn |
| Dec 31, 2024 | 49.41 Mn |
| Sep 30, 2024 | 48.64 Mn |
| Jun 30, 2024 | 47.91 Mn |
| Mar 31, 2024 | 41.38 Mn |
| Dec 31, 2023 | 42.92 Mn |
| Sep 30, 2023 | 41.27 Mn |
| Jun 30, 2023 | 38.16 Mn |
| Mar 31, 2023 | 36.66 Mn |
| Dec 31, 2022 | 36.16 Mn |
| Sep 30, 2022 | 36.96 Mn |
| Jun 30, 2022 | 34.45 Mn |
| Mar 31, 2022 | 31.01 Mn |
| Dec 31, 2021 | 31.54 Mn |
| Sep 30, 2021 | 31.20 Mn |
| Jun 30, 2021 | 33.58 Mn |